Evidence map›Paper›PMID 26037121›Full record

ArticlemBio2015

Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.

Glen P Carter, Anjana Chakravorty, Tu Anh Pham Nguyen, Steven Mileto, Fernanda Schreiber, Lucy Li, Pauline Howarth, Simon Clare, Bliss Cunningham, Susan P Sambol and 8 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 175 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
175citing papers in PubMed, 1 pooled it
19.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

175 citing papers in PubMed, 1 synthesis or guideline pooled it, 335 citations in OpenAlex.

  1. Pooled it
  2. Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Trial
  3. BeyondEmerging microbes & infections · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Toxins · 2026
    Article
  9. Article
  10. Article
  11. Cytoplasmic membrane vesicles fromFrontiers in microbiology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Identification of risk factors forWorld journal of gastroenterology · 2025
    Article
  19. Review
  20. Review

115 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 3 countries.

Glen P CarterDepartment of Microbiology, Monash University, Victoria, Australia.
Anjana ChakravortyDepartment of Microbiology, Monash University, Victoria, Australia.
Tu Anh Pham NguyenWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Steven MiletoDepartment of Microbiology, Monash University, Victoria, Australia.
Fernanda SchreiberWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Lucy LiDepartment of Microbiology, Monash University, Victoria, Australia.
Pauline HowarthDepartment of Microbiology, Monash University, Victoria, Australia.
Simon ClareWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Bliss CunninghamDepartment of Microbiology, Monash University, Victoria, Australia.
Susan P Sambol
Adam Cheknis
Iris Figueroa
Stuart Johnson
Dale Gerding
Julian I RoodDepartment of Microbiology, Monash University, Victoria, Australia.ORCID http://orcid.org/0000-0003-2126-7209
Gordon DouganWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Trevor D LawleyWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Dena LyrasDepartment of Microbiology, Monash University, Victoria, Australia Dena.Lyras@monash.edu.
Monash University · AULoyola University Chicago · USWellcome Sanger Institute · GB

Funding

Medical Research Council 93614Wellcome TrustWellcome Trust 086418Wellcome Trust 098051
6 · The paper itself

Abstract

unlabelledClostridium difficile is a leading cause of antibiotic-associated diarrhea, a significant animal pathogen, and a worldwide public health burden. Most disease-causing strains secrete two exotoxins, TcdA and TcdB, which are considered to be the primary virulence factors. Understanding the role that these toxins play in disease is essential for the rational design of urgently needed new therapeutics. However, their relative contributions to disease remain contentious. Using three different animal models, we show that TcdA(+) TcdB(-) mutants are attenuated in virulence in comparison to the wild-type (TcdA(+) TcdB(+)) strain, whereas TcdA(-) TcdB(+) mutants are fully virulent. We also show for the first time that TcdB alone is associated with both severe localized intestinal damage and systemic organ damage, suggesting that this toxin might be responsible for the onset of multiple organ dysfunction syndrome (MODS), a poorly characterized but often fatal complication of C. difficile infection (CDI). Finally, we show that TcdB is the primary factor responsible for inducing the in vivo host innate immune and inflammatory responses. Surprisingly, the animal infection model used was found to profoundly influence disease outcomes, a finding which has important ramifications for the validation of new therapeutics and future disease pathogenesis studies. Overall, our results show unequivocally that TcdB is the major virulence factor of C. difficile and provide new insights into the host response to C. difficile during infection. The results also highlight the critical nature of using appropriate and, when possible, multiple animal infection models when studying bacterial virulence mechanisms. IMPORTANCE: Clostridium difficile is a leading cause of antibiotic-associated diarrhea and an important hospital pathogen. TcdA and TcdB are thought to be the primary virulence factors responsible for disease symptoms of C. difficile infections (CDI). However, the individual contributions of these toxins to disease remain contentious. Using three different animal models of infection, we show for the first time that TcdB alone causes severe damage to the gut, as well as systemic organ damage, suggesting that this toxin might be responsible for MODS, a serious but poorly understood complication of CDI. These findings provide important new insights into the host response to C. difficile during infection and should guide the rational development of urgently required nonantibiotic therapeutics for the treatment of CDI.

Indexed as

AnimalsBacterial ProteinsBacterial ToxinsBoron CompoundsClostridioides difficileClostridium InfectionsDisease Models, AnimalEnterotoxinsGastrointestinal DiseasesGene Knockout TechniquesMultiple Organ FailureVirulenceVirulence FactorsBacterial ProteinsBacterial ToxinsBoron CompoundsEnterotoxinstcdA protein, Clostridium difficiletoxB protein, Clostridium difficiletrimethylaminocarboxyldihydroboranVirulence Factors

Identifiers

PMID26037121
PMCPMC4453007
OpenAlexW2123458607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.